EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2

Embrace2

Peace of Mind

No longer available for purchase

Empatica Logo
  • Solutions

    Empatica Health Monitoring Platform

    Empatica Health Monitoring Platform

    One platform, multiple applications

    Components

    EmbracePlus wearable
    EmbraceMini wearable
    New
    Care software suite
    eCOA
    Digital biomarkers
    Cloud API for Clinical Trials

    Use Cases

    Clinical Trials
    Designed for the patient, enhanced for the scientist
    Actigraphy
    The new standard to measure sleep and physical activity
    Contract Research Organizations
    Enhanced value and effortless integrations for CROs
    Parkinson's Monitoring
    New
    Improve patient outcomes with validated PKG measures
    Parkinson’s & Movement Disorders
    Digital endpoints for Parkinson's and movement disorders trials
    Academic Research
    Unlock the future of real-world research
    Go to store
  • Scientific Evidence

    Publications
    Scientific publications using our technology
    Case Studies
    Client success stories
  • Resources

    Compliance
    Global regulatory requirements
    Blog
    Thoughts and news
    Digital resources library
    Online and downloadable resources
    Support center
    Get support with our products
  • Company

    About us
    People with purpose
    Careers
    Join the mission
    Contact us
    Talk to our team
Contact Us
Empatica Logo
Empatica Health Monitoring Platform

Empatica Health Monitoring Platform

One platform, multiple applications

Components

EmbracePlus wearable
EmbraceMini wearable
New
Care software suite
eCOA
Digital biomarkers
Cloud API for Clinical Trials

Use Cases

Clinical Trials
Designed for the patient, enhanced for the scientist
Actigraphy
The new standard to measure sleep and physical activity
Contract Research Organizations
Enhanced value and effortless integrations for CROs
Parkinson's Monitoring
New
Improve patient outcomes with validated PKG measures
Parkinson’s & Movement Disorders
Digital endpoints for Parkinson's and movement disorders trials
Academic Research
Unlock the future of real-world research
Go to store
Publications
Scientific publications using our technology
Case Studies
Client success stories
Compliance
Global regulatory requirements
Blog
Thoughts and news
Digital resources library
Online and downloadable resources
Support center
Get support with our products
About us
People with purpose
Careers
Join the mission
Contact us
Talk to our team
EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2
Embrace2

Peace of Mind

No longer available for purchase

Contact Us
News

Empatica joining DiMe in developing a core set of digital measures for physical activity

Empatica

Empatica

Oct 20, 2022• 2 min read

LinkedinFacebookX

Empatica partners with DiMe as a collaborater on project to develop cores set of measures of physical activity

We are excited to announce that Empatica is embarking on a project with the Digital Medicine Society (DiMe) and other select partners to develop a set of core digital measures of physical activity. Measures of physical activity are increasingly being considered the “6th vital sign,” due to their potential impact in assessing and monitoring a vast range of conditions, across therapeutic areas and patient populations.

Though multiple measures of physical activity currently exist, they have been developed using varying technology and methods. The goal of the DiMe project is to eventually create a reliable library of endpoints, so that medical products can be approved based on broadly accepted digital measures. By combining reliable digital biomarkers with mature sensor technology, digital measures can be created that favor patients, caregivers, clinicians, and scientists. By developing a set of measures that are disease agnostic, patients can benefit from monitoring that can be better suited to their condition, and developed on technology that can be trusted.

Empatica’s technology and expertise in digital biomarker development will contribute to capturing data from daily life and determining a scientific strategy to define and develop the final set of algorithms that can compute the measures.

Subscribe to our Research newsletter or follow Empatica on Twitter and Linkedin to stay informed about new project developments.

If you have questions about Empatica's technology and how our solutions can help in digital biomarker development and scientific research, reach out to our team by writing to research@empatica.com.

Company
About us
Careers
Legal
Blog
Empatica Health Monitoring Platform
Clinical Trials
Academic Research
Actigraphy
Parkinson's Monitoring
Parkinson’s & Movement Disorders
Log in
Care Portal
Care Lab Portal
Research Portal
Epilepsy Monitoring
EpiMonitor
Embrace2
Get Support
Contact Us
Manuals
Empatica
FacebookInstagramYouTubeTwitterLinkedin

Empatica Inc., 1 Broadway, 14th floor, Cambridge MA 02142 United States - Empatica Srl, Via Stendhal 36, 20144 Milano (MI), Italy

P. IVA IT07462810966. Copyright © 2026 Empatica Inc. - ISO 13485 Cert. No. 39050072201 - All rights reserved - Legal